schliessen

Filtern

 

Bibliotheken

6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen

Journal Title: European Journal of Cancer 2011, Vol.47, pp.S465-S465
Main Author: Nishina, T
Other Authors: Sasaki, Y , Yasui, H , Takiuchi, H , Tsuji, A , Muro, K , Koizumi, W , Toh, Y , Hara, T , Miyata, Y
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: ScienceDirect Journals (Elsevier)
ID: ISSN: 0959-8049 ; E-ISSN: 1879-0852 ; DOI: 10.1016/S0959-8049(11)71890-1
Link: http://dx.doi.org/10.1016/S0959-8049(11)71890-1
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: elsevier_sdoi_10_1016_S0959_8049_11_71890_1
title: 6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen
format: Article
creator:
  • Nishina, T
  • Sasaki, Y
  • Yasui, H
  • Takiuchi, H
  • Tsuji, A
  • Muro, K
  • Koizumi, W
  • Toh, Y
  • Hara, T
  • Miyata, Y
subjects:
  • Medicine
ispartof: European Journal of Cancer, 2011, Vol.47, pp.S465-S465
description:
language: eng
source: ScienceDirect Journals (Elsevier)
identifier: ISSN: 0959-8049 ; E-ISSN: 1879-0852 ; DOI: 10.1016/S0959-8049(11)71890-1
fulltext: fulltext
issn:
  • 0959-8049
  • 09598049
  • 1879-0852
  • 18790852
url: Link


@attributes
ID1196726618
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordiddoi_10_1016_S0959_8049_11_71890_1
sourceidelsevier_s
recordidTN_elsevier_sdoi_10_1016_S0959_8049_11_71890_1
sourcesystemPC
dbid
0--K
1--M
2.FO
3.~1
41B1
51P~
61~.
7457
84G.
97-5
108P~
119JM
12AABNK
13AAEDT
14AAKOC
15AAOAW
16AAQFI
17ABBQC
18ABFNM
19ABGSF
20ABMZM
21ABYKQ
22ACDAQ
23ACIUM
24ACRLP
25ADALY
26ADUVX
27AEHWI
28AEKER
29AEVXI
30AFKWA
31AFTJW
32AFXIZ
33AGHFR
34AGRDE
35AGUBO
36AGYEJ
37AHHHB
38AIKHN
39AITUG
40AJBFU
41AJOXV
42AJRQY
43AJUYK
44AMFUW
45ANZVX
46BLXMC
47BNPGV
48DOVZS
49EO8
50EO9
51EP2
52EP3
53FDB
54FGOYB
55FIRID
56FNPLU
57G-Q
58GBLVA
59HED
60HMK
61HMO
62J1W
63KOM
64LCYCR
65OAUVE
66OC~
67OO-
68P-8
69P-9
70PC.
71Q38
72R2-
73RPZ
74SAE
75SCC
76SDF
77SDG
78SDP
79SEL
80SES
81SEW
82SSH
83SSU
84SSZ
85T5K
86UV1
87Z5R
88~G-
display
typearticle
title6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen
creatorNishina, T ; Sasaki, Y ; Yasui, H ; Takiuchi, H ; Tsuji, A ; Muro, K ; Koizumi, W ; Toh, Y ; Hara, T ; Miyata, Y
ispartofEuropean Journal of Cancer, 2011, Vol.47, pp.S465-S465
identifier
subjectMedicine
languageeng
sourceScienceDirect Journals (Elsevier)
version2
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1016/S0959-8049(11)71890-1$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
search
creatorcontrib
0Nishina, T
1Sasaki, Y
2Yasui, H
3Takiuchi, H
4Tsuji, A
5Muro, K
6Koizumi, W
7Toh, Y
8Hara, T
9Miyata, Y
title6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen
subjectMedicine
general
0English
1Elsevier Ltd
210.1016/S0959-8049(11)71890-1
3ScienceDirect (Elsevier)
4ScienceDirect Journals (Elsevier)
sourceidelsevier_s
recordidelsevier_sdoi_10_1016_S0959_8049_11_71890_1
issn
00959-8049
109598049
21879-0852
318790852
rsrctypearticle
creationdate2011
addtitleEuropean Journal of Cancer
searchscope
0elsevier_full
1elsevier2
scope
0elsevier_full
1elsevier2
lsr44$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
tmp01ScienceDirect Journals (Elsevier)
tmp02
0--K
1--M
2.FO
3.~1
41B1
51P~
61~.
7457
84G.
97-5
108P~
119JM
12AABNK
13AAEDT
14AAKOC
15AAOAW
16AAQFI
17ABBQC
18ABFNM
19ABGSF
20ABMZM
21ABYKQ
22ACDAQ
23ACIUM
24ACRLP
25ADALY
26ADUVX
27AEHWI
28AEKER
29AEVXI
30AFKWA
31AFTJW
32AFXIZ
33AGHFR
34AGRDE
35AGUBO
36AGYEJ
37AHHHB
38AIKHN
39AITUG
40AJBFU
41AJOXV
42AJRQY
43AJUYK
44AMFUW
45ANZVX
46BLXMC
47BNPGV
48DOVZS
49EO8
50EO9
51EP2
52EP3
53FDB
54FGOYB
55FIRID
56FNPLU
57G-Q
58GBLVA
59HED
60HMK
61HMO
62J1W
63KOM
64LCYCR
65OAUVE
66OC~
67OO-
68P-8
69P-9
70PC.
71Q38
72R2-
73RPZ
74SAE
75SCC
76SDF
77SDG
78SDP
79SEL
80SES
81SEW
82SSH
83SSU
84SSZ
85T5K
86UV1
87Z5R
88~G-
startdate20110101
enddate20111231
lsr40European Journal of Cancer, 2011, Vol.47, pp.S465-S465
doi10.1016/S0959-8049(11)71890-1
citationpf S465 pt S465 vol 47
sort
title6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen
authorNishina, T ; Sasaki, Y ; Yasui, H ; Takiuchi, H ; Tsuji, A ; Muro, K ; Koizumi, W ; Toh, Y ; Hara, T ; Miyata, Y
creationdate20110000
lso0120110000
facets
frbrgroupid428366060103036737
frbrtype5
newrecords20190904
languageeng
topicMedicine
collectionScienceDirect (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Nishina, T
1Sasaki, Y
2Yasui, H
3Takiuchi, H
4Tsuji, A
5Muro, K
6Koizumi, W
7Toh, Y
8Hara, T
9Miyata, Y
jtitleEuropean Journal of Cancer
creationdate2011
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Nishina
1Sasaki
2Yasui
3Takiuchi
4Tsuji
5Muro
6Koizumi
7Toh
8Hara
9Miyata
aufirst
0T
1Y
2H
3A
4K
5W
auinitT
auinit1T
au
0Nishina, T
1Sasaki, Y
2Yasui, H
3Takiuchi, H
4Tsuji, A
5Muro, K
6Koizumi, W
7Toh, Y
8Hara, T
9Miyata, Y
atitle6579 POSTER Phase II Study of ABI-007 Given as an Every Three Weeks Schedule for Japanese Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-fluorouracil (5-FU) Containing Regimen
jtitleEuropean Journal of Cancer
date2011
risdate2011
volume47
spageS465
epageS465
pagesS465-S465
issn0959-8049
eissn1879-0852
formatjournal
genrearticle
ristypeJOUR
pubElsevier Ltd
doi10.1016/S0959-8049(11)71890-1
lad01European Journal of Cancer